http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2514335-C3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
filingDate 1975-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1980-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1980-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-2514335-C3
titleOfInvention Oral drug with antiplasmin inhibitory effect
priorityDate 1974-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546362
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453335048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411174056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421451112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449868975
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54215275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451265449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23666345
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425407997

Total number of triples: 30.